NCT06876350NARecruiting

Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

Foundation for Orthopaedic Research and Education

Start Date

10/3/2024

Completion Date

6/30/2025

Summary

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.

Detailed Description

Patients undergoing carpometacarpal arthroplasty will be randomized into the woodcast or thermoplast splint after their surgery to see which is preferred using compliance and surveys.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients over the age of 18 years old. * Intact Medical Decision Making * Eligible for Surgical Intervention * Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks Exclusion Criteria: * Pregnant Women * Deemed Unsuitable by Principal Investigator

Interventions

OTHER

Woodcasting Splint

OTHER

Control (Standard treatment)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Carpometacarpal (CMC) Joint Arthritis

Locations

Florida Orthopaedic Institute

Tampa, Florida 33637

United States